Endocrine Abstracts

Background: Through the decades, aromatase inhibitor maintenance therapy for patients with postmenopausal non-metastatic estrogen receptor-positive breast cancer has improved significantly. This study focuses on the patient’s further breast cancer course and clarifies the extensive symptom burden that the endocrinologist should be aware of.Aim: The study aims to gain insight into a potential gap between the endocrine symptoms outlined in guidelines ...